A comparative study of chest MRI in respiratory diseases

A comparative study of chest MRI in respiratory diseases - Chest MRI in respiratory diseases

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000025253

Enrollment

200

Registered

2017-01-01

Start date

2016-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung/mediastinal tumors, Interstitial pneumonia, Pulmonary emphysema, COPD, Sarcoidosis, Hypersensitivity pneumonitis, Mycobacteriosis, Fungal diseases

Interventions

Chest MRI: examination and interpretation Chest HRCT: examination and interpretation

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) Patients who undergoes chest CT as a part of clinical examination (2) Lung/mediastinal tumors, Interstitial pneumonia, Pulmonary emphysema, COPD, Sarcoidosis, Hypersensitivity pneumonitis, Mycobacteriosis, Fungal diseases (3) Male & Female (4) Informed consent (5) Repeated examination

Exclusion criteria

Exclusion criteria: (1) General contraindications for undergoing an MRI as followings 1. Patients who is pregnant 2. Patients with severe claustrophobia 3. Patients who have a heart pacemaker 4. Patients who have an artificial inner ear 5. Patients who have an prosthetic valves 6. Patients is in post-operative status for cerebral aneurysm 7. Patients with dental implants 8. Patients with a tattoo 9. Patients who have the other metallic foreign bodies 10. Patients who is underage (20>) (2) Patients who cannot keep resting status at the examination (3) Patients who is under a critical condition (4) Patients who (5) Patients without written informed consent (6) Patients who is regarded as inappropriate by researchers to enroll the study

Design outcomes

Primary

Measure	Time frame
To investigate the diagnostic accuracy for detection and characterization in respiratory diseases by HRCT & MRI (T1WI, T2WI, UTE, DWI, etc), and determine the reproducibility in the subjective parameters (kappa analysis) and objective measurements (T2*value, T2value, ADC etc)	—

Secondary

Measure	Time frame
To find the useful MRI findings in clinical settings	—

Countries

Japan

Contacts

Public ContactSatoshi Kawanami

Kyushu University, Graduate School of Medical Sciences Molecular Imaging & Diagnosis

r-wave@radiol.med.kyushu-u.ac.jp092-642-5695

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026